- Home
- GTE vs SMTI Comparison
GTE vs SMTI Comparison
Compare GTE & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- SMTI
- Stock Information
- Founded
- GTE 2003
- SMTI 1982
- Country
- GTE Canada
- SMTI United States
- Employees
- GTE N/A
- SMTI N/A
- Industry
- GTE Oil & Gas Production
- SMTI Medical/Dental Instruments
- Sector
- GTE Energy
- SMTI Health Care
- Exchange
- GTE Nasdaq
- SMTI Nasdaq
- Market Cap
- GTE 253.1M
- SMTI 288.2M
- IPO Year
- GTE N/A
- SMTI N/A
- Fundamental
- Price
- GTE $6.59
- SMTI $31.87
- Analyst Decision
- GTE Hold
- SMTI Buy
- Analyst Count
- GTE 1
- SMTI 1
- Target Price
- GTE $10.00
- SMTI $44.00
- AVG Volume (30 Days)
- GTE 301.1K
- SMTI 27.4K
- Earning Date
- GTE 10-29-2024
- SMTI 11-11-2024
- Dividend Yield
- GTE N/A
- SMTI N/A
- EPS Growth
- GTE 7.45
- SMTI N/A
- EPS
- GTE 1.56
- SMTI N/A
- Revenue
- GTE $658,051,000.00
- SMTI $72,410,222.00
- Revenue This Year
- GTE $11.16
- SMTI $26.97
- Revenue Next Year
- GTE $20.54
- SMTI $18.91
- P/E Ratio
- GTE $4.15
- SMTI N/A
- Revenue Growth
- GTE 3.94
- SMTI 21.42
- 52 Week Low
- GTE $4.72
- SMTI $26.00
- 52 Week High
- GTE $10.40
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- GTE 49.39
- SMTI 52.18
- Support Level
- GTE $6.20
- SMTI $30.29
- Resistance Level
- GTE $6.62
- SMTI $32.95
- Average True Range (ATR)
- GTE 0.32
- SMTI 1.58
- MACD
- GTE 0.09
- SMTI 0.32
- Stochastic Oscillator
- GTE 60.67
- SMTI 76.77
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. It is engaged in the acquisition, exploration, development, and production of oil and gas properties. The firm produces light crude oil, supplemented with medium crude and natural gas. Gran Tierra holds interests in producing and prospective properties in Colombia and prospective properties in Ecuador. The company derives its revenue from Colombia.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.